TrialBMC gastroenterology2007

Efficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infection.

José M Navarro-Jarabo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.